Kelun-Biotech and Windward Bio Forge Strategic Collaboration for TSLP Monoclonal Antibody Development Sichuan Kelun-Biotech Biopharmaceutical Co. has partnered with Windward Bio to develop SKB378/HBM9378, a promising monoclonal antibody targeting severe respiratory diseases.

Kelun-Biotech and Windward Bio Forge Strategic Collaboration for TSLP Monoclonal Antibody Development #China #Chengdu #Kelun-Biotech #Windward_Bio #TSLP_Antibody